Amneal Pharmaceuticals (AMRX) Change in Cash (2017 - 2026)
Amneal Pharmaceuticals (AMRX) posted quarterly Change in Cash of -$108.5 million for Q1 2026, down 116.95% year-over-year from $640.3 million in Q1 2025, and down 245.62% quarter-over-quarter from $74.5 million in Q4 2025.
Amneal Pharmaceuticals (AMRX) Change in Cash (2017 - 2026) Analysis & Trends
Amneal Pharmaceuticals' Change in Cash history runs 10 years deep, the most recent figure standing at -$108.5 million for Q1 2026.
- In Q1 2026, Change in Cash fell 116.95% year-over-year to -$108.5 million; the TTM figure through Mar 2026 stood at $136.0 million (up 710.72% YoY), while the FY2025 annual figure was $194.5 million, up 907.19% from the prior year.
- Change in Cash for Q1 2026 stood at -$108.5 million, down from $74.5 million in the prior quarter.
- The five-year high for Change in Cash was $154.7 million in Q3 2025, with the low at -$118.4 million in Q2 2022.
- The 5-year median for Change in Cash is -$2.3 million (2022), against an average of -$3.1 million.
- The sharpest annual moves came in 2023 and 2024: Change in Cash plunged 728.24% in 2023, then soared 1045.0% in 2024.
- Amneal Pharmaceuticals' Change in Cash stood at -$60.7 million in 2022, then soared by 105.77% to $3.5 million in 2023, then jumped by 1045.0% to $40.1 million in 2024, then jumped by 85.98% to $74.5 million in 2025, then plunged by 245.62% to -$108.5 million in 2026.
- Business Quant data shows AMRX's Change in Cash at -$108.5 million in Q1 2026, $74.5 million in Q4 2025, and $154.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | -86.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -465.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -915.70 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 102.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Amneal Pharmaceuticals | 5.72 Bn | 5.59 Bn | 334.51 Mn | -64.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -64.79 Mn |
| Mar 31, 2026 | -108.53 Mn |
| Dec 31, 2025 | 74.53 Mn |
| Sep 30, 2025 | 154.74 Mn |
| Jun 30, 2025 | 15.28 Mn |
| Mar 31, 2025 | -50.03 Mn |
| Dec 31, 2024 | 40.08 Mn |
| Sep 30, 2024 | 28.72 Mn |
| Jun 30, 2024 | -2.00 Mn |
| Mar 31, 2024 | -47.49 Mn |
| Dec 31, 2023 | 3.50 Mn |
| Sep 30, 2023 | -18.98 Mn |
| Jun 30, 2023 | -36.49 Mn |
| Mar 31, 2023 | 115.84 Mn |
| Dec 31, 2022 | -60.66 Mn |
| Sep 30, 2022 | -2.29 Mn |
| Jun 30, 2022 | -118.36 Mn |
| Mar 31, 2022 | -40.19 Mn |
| Dec 31, 2021 | -53.88 Mn |
| Sep 30, 2021 | 27.47 Mn |